Periodontal Diseases Therapeutics Market; Evolving Treatment Strategies by 2019

Periodontal (gums) diseases include infections of gums and its surrounding tissue which causes loosening of teeth. There are two forms of periodontal diseases which include gingivitis and periodontitis. Gingivitis is inflammation of gums and usually precedes periodontitis. Timely treatment of gingivitis leads to healthy gums, but if the inflammation is left unnoticed, it may lead to periodontitis causing an irreversible damage. Oral health is a growing concern across the globe, where around 45% of the Americans suffered from periodontitis in 2012 according to American Academy of Periodontology.

Download Complete Report Brochure Get Industry Insight:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2026

The study also indicated that the prevalence is higher in men (56%) as compared to women. According to Oral Health European Platform, an association for dental care, around 50% of the European population suffers from some periodontal disease. Similar statistics were discussed by a review article published title Global Prevalence on Periodontitis in 2012. According to the article, prevalence of severe periodontitis was in the range of 20-30% in India, while in Bangladesh, Canada and Germany it was more than 20%. The data statistics indicate that a large market opportunity exists because of the high prevalence of periodontal diseases worldwide.

The market for periodontal disease therapeutics can be segmented by therapeutic drugs as below:

Drug Therapy

PerioChip

Arestin

Atridox

Periostat

The market for periodontal disease therapeutics is leveraged by the rising prevalence of diabetes which is one of the major predisposing factors for infections in the body including gums. Smoking, hormonal changes are other reasons which lead to gum problems. With rising awareness about oral health and hygiene, the market is expected to grow in Asia-Pacific and other countries in Latin America and the Middle East. Cost of branded drugs is...